The HSA (Health Sciences Authority) is responsible to regulating health products ensuring that they meet all the necessary standards of safety, quality and efficacy.
They have set a fee applicable for registration, licensing, permit issuance, and notification for medical devices, therapeutic products, cosmetic products, cell tissue & gene therapy, oral dental gums, and Chinese proprietary medicines.
In the latest update, it has been issued that there is going to be a 5% hike in fee effective from 1 July 2024. You can expect the minimum increase of $1 and capped at $200 per fee item. The increase in this cost is to recover part of the costs for the services rendered to businesses.
Below, we have list of revised fee –
⦿ Cell, Tissues, or Gene Therapy products (CTGTP)
⦿ Medical advertisements & sale promotion
⦿ Controlled Drugs and Psychotropic Substances
⦿ Chinese Proprietary Medicines
HSA will continue to streamline our processes and deliver value to all the stakeholders.
Keep following Elexes for latest updates.
